Compare COCO & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COCO | LIVN |
|---|---|---|
| Founded | 2004 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.5B |
| IPO Year | 2021 | 2015 |
| Metric | COCO | LIVN |
|---|---|---|
| Price | $65.97 | $78.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | $57.75 | ★ $72.43 |
| AVG Volume (30 Days) | ★ 1.3M | 549.7K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.60 | N/A |
| EPS | ★ 1.32 | 0.40 |
| Revenue | N/A | N/A |
| Revenue This Year | $16.12 | $9.79 |
| Revenue Next Year | $11.40 | $6.63 |
| P/E Ratio | ★ $49.98 | $195.48 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $31.82 | $41.02 |
| 52 Week High | $85.83 | $85.27 |
| Indicator | COCO | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 37.21 | 49.91 |
| Support Level | $65.11 | $61.63 |
| Resistance Level | $69.59 | $80.96 |
| Average True Range (ATR) | 3.87 | 2.28 |
| MACD | -0.58 | -0.64 |
| Stochastic Oscillator | 4.48 | 49.42 |
The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.